In vitro activation of lymphocytes with interleukin 2 (IL-2) generates a population of cytotoxic effector cells with broad antitumor activity. However, it is unclear if this recognition is via a heterogeneous population of lymphokine-activated killer (LAK) cells or via a distinct set of select membrane structures common in LAK-sensitive target cells. The investigators' studies indicate that human LAK cells also have the ability to lyse autologous and allogeneic monocytes. In addition, monocyte susceptibility to LAK lysis is found to increase with in vitro culture and differentiation of the monocytes with granulocyte-macrophage colony stimulating factor (GM-CSF) or interleukin 3 (IL-3) further enhances their susceptibility. On the other hand, IFN-gamma is able to downregulate monocyte susceptibility. More importantly, GM-CSF-treated monocytes efficiently compete with tumor cells for LAK lysis suggesting that they may share common NK/LAK recognizable structures. The ability of CSF and IFN-gamma to differentially modulate target susceptibility in monocytes provides a unique opportunity to investigate the target structure(s) recognized by LAK cells on monocytes that might be shared with tumor cells. The questions to be asked are: 1) are known adhesion molecules such as LFA1,2,3, as well as CD16 and CD56 involved in LAK recognition of monocytes? 2) is there a putative NK/LAK target structure other than adhesion molecules involved in initial binding of LAK cells to monocyte? 3) what is the biological significance of LAK lysis of monocytes and is it a means to eliminate unwanted monocytes that have already performed their function such as antigen presentation? 4) is clearance of monocytes via lysis and DNA fragmentation caused by LAK granule components or by autologous enzymes leading to programmed cell death? Work outlined in this proposal should lead to an understanding of the mechanism of LAK recognition of monocytes at the biological, biochemical and molecular levels and give some insight into the role of LAK cells in immunoregulation via control of monocytes and their functions.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA046820-04
Application #
3190245
Study Section
Immunobiology Study Section (IMB)
Project Start
1988-05-01
Project End
1994-04-30
Budget Start
1991-05-01
Budget End
1992-04-30
Support Year
4
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of South Florida
Department
Type
Schools of Medicine
DUNS #
City
Tampa
State
FL
Country
United States
Zip Code
33612
Epling-Burnette, P K; Garcia, Roy; Bai, Fanqi et al. (2002) Carboxy-terminal truncated STAT5 is induced by interleukin-2 and GM-CSF in human neutrophils. Cell Immunol 217:1-11
Wei, S; Liu, J H; Epling-Burnette, P K et al. (2000) IL-2 induces the association of IL-2Rbeta, lyn, and MAP kinase ERK-1 in human neutrophils. Immunobiology 202:363-82
Michelini-Norris, M B; Diaz, J; Roberts, W S et al. (1995) An alternative medium supplement for the culturing and growth of human peritoneal mesothelial cells. In Vitro Cell Dev Biol Anim 31:487-91
Gamero, A M; Ussery, D; Reintgen, D S et al. (1995) Interleukin 15 induction of lymphokine-activated killer cell function against autologous tumor cells in melanoma patient lymphocytes by a CD18-dependent, perforin-related mechanism. Cancer Res 55:4988-94
Epling-Burnette, P K; Wei, S; Liu, J H et al. (1995) Expression of interleukin-2 receptor gamma on human monocytes: characterization of lineage specific post-translational modifications. Eur J Immunol 25:291-4
Barton, D P; Blanchard, D K; Duan, C et al. (1995) Interleukin-12 synergizes with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid. J Soc Gynecol Investig 2:762-71
Liu, J H; Wei, S; Ussery, D et al. (1994) Expression of interleukin-2 receptor gamma chain on human neutrophils. Blood 84:3870-5
Pericle, F; Liu, J H; Diaz, J I et al. (1994) Interleukin-2 prevention of apoptosis in human neutrophils. Eur J Immunol 24:440-4
Barton, D P; Blanchard, D K; Wells, A F et al. (1994) Expression of interleukin-2 receptor alpha (IL-2R alpha) mRNA and protein in advanced epithelial ovarian cancer. Anticancer Res 14:761-72
Wei, S; Liu, J H; Blanchard, D K et al. (1994) Induction of IL-8 gene expression in human polymorphonuclear neutrophils by recombinant IL-2. J Immunol 152:3630-6

Showing the most recent 10 out of 24 publications